We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go: Stretch investment: Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go: Stretch investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Kokoon is a digital platform that offers personalised, clinically approved, intelligent audio content and coaching for better sleep and relaxation. The company has also introduced a set of ergonomic headphones that work seamlessly with the Kokoon app and encourages and protects relaxation and sleep. The company has also been featured in esteemed platforms such as BBC, HuffPost, and The Guardian. Since its inception 4 years ago, Kokoon has received over £4.5m in online sales, scaled manufacturing to 6000 units per month, won an Innovate UK Government Grant and has 5 international patents in its portforlio. Going forward, Kokoon aims to become a world-leading technology brand, positively changing the lives of millions. 
days to go: Expired investment: £1,654,936
The Ethical Butcher (TEB) is a premium, sustainable and ethical online butcher on a mission to spearhead the craft meat revolution. It has partnered with farmers who practise regenerative agriculture and supplies premium quality meat to the restaurant industry throughout London. TEB claims that its meat is 100% pasture-fed and free from hormones and antibiotics. It has served 10,500 orders to 5,000 customers. TEB generated £789,000 in revenue and £141,000 in profit in 2020. TEB asserts that it has an ‘Excellent’ rating on Trustpilot, featured on news entities such as The Telegraph, The Times, and BBC Good Food, and claims to be the first and only online Pasture-Fed Livestock Association (PFLA) certified butcher in London. The company points out that it has 478,000 website visitors and intends to use the investment to accelerate the growth of its B2C business and scale its meat production.

Pitch Rated

80%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £1,592,648
Assetz Capital is an FCA authorized, major business secured by property and P2P lender in the Europe and UK. Funded by 30,000+ lenders, the company provides loans to property developers and SMEs in the UK. Assetz Capital was ranked 53rd out of the UK’s top 100 fastest-growing technology companies in the Sunday Times Tech Track 100. Moreover, the company has witnessed a 78% average revenue growth over three years. Having achieved critical mass and proven business model, Assetz Capital is headed towards meeting the multi-billion funding gap faced by SMEs. With the proceeds, the company will strengthen the cash levels and balance sheet and provide further opportunities to shareholders and customers.
days to go: Expired investment: £1,866,500
Easily understand and manage all your insurance in one simple app, ready for the digital age. Wrisk is all about transparency and allows customers to see how much they’re currently paying for their insurance, what actions they can take to reduce their risk and purchase the insurance seamlessly from within the app. Wrisk is seeking investment to expand and cater for as many insurance needs as possible. 
days to go: Expired investment: £1,044,630
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph